Featured News
A Novel Microfluid Liver-on-Chip Model
Application of microfluidic 3D liver chip models for genotoxicity testing
Genotoxicity is based on a combination of tests to assess different endpoints linked to human diseases: mutagenicity, clastogenicity and aneuploidy. Our novel microfluid liver-on-chip model provides a cutting-edge solution for regulated genotoxicity testing, delivering high accuracy and human-relevant results while reducing the need for animal testing. With our technology, we offer clients a reliable and ethical system for studying liver function and toxicity, which can help to streamline regulatory approval processes and protect both human health and animal welfare.
Have a question or want more information from our scientists?
Successfully Navigate Genetic Toxicology Testing Requirements
In this webinar, our experts share thoughts on testing strategies and approaches to address adverse genetic toxicology results. Watch to broaden your understanding of genetic toxicology testing so you can bring your drug to market safely, swiftly, and effectively.
Watch the Webinar